Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
CORCEPT THERAPEU RG (NQ: CORT)
13.90 USD  -0.23 (-1.63%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 17, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,139,997
Open 14.15
Bid (Size) 13.60 (100)
Ask (Size) 14.25 (200)
Prev. Close 14.13
Today's Range 13.79 - 14.16
52wk Range 11.88 - 25.96
Shares Outstanding 115,235,013
Dividend Yield N/A
Performance
YTD
-23.37%
-23.37%
1 Month
-17.65%
-17.65%
3 Month
-20.96%
-20.96%
6 Month
-34.77%
-34.77%
1 Year
+14.31%
+14.31%
Top News
More News
Analysis: Positioning to Benefit within QEP Resources, Corcept Therapeutics, Buckle, Noble Energy, Windstream, and Camden Property Trust — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of QEP Resources, Inc.... Read More
from GlobeNewswire News Releases
Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting
Corcept Therapeutics Incorporated (NASDAQ:CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric... Read More
from GlobeNewswire News Releases
More News
Read More
Market Trends Toward New Normal in Agios Pharmaceuticals, Corcept Therapeutics, Prestige Brand, Virtu Financial, Eagle Pharmaceuticals, and Century Aluminum — Emerging Consolidated Expectations, Analy
from GlobeNewswire News Releases
Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress
from GlobeNewswire News Releases
Stocks To Watch: Corcept Therapeutics Sees RS Rating Jump To 91
from Investor's Business Daily
Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update
from GlobeNewswire News Releases
Corcept Therapeutics Becomes Oversold (CORT)
category Stocks
from Market News Video
Corcept Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Threshold
from Investor's Business Daily
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
from GlobeNewswire News Releases
Stock Upgrades: Corcept Therapeutics Shows Rising Relative Strength
from Investor's Business Daily
Noteworthy Monday Option Activity: WTW, CORT, PGNX
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.